NASDAQ | ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the index.
Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies.
The index may include securities of large-, mid- and small-capitalization companies.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 7.68% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 7.57% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 7.56% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 6.24% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 4.84% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 4.64% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 2.25% |
| SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 2.14% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 2.10% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.05% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 1.67% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 1.60% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.55% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 1.53% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 1.41% |
| SNY | Sanofi ADR | Healthcare | Drug Manufacturers - General | 1.40% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.36% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.31% |
| BGNE | BeiGene Ltd | Healthcare | Biotechnology | 1.31% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 1.29% |